9HVI
 
 | | PSMA in complex with nanobody 8 | | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, CALCIUM ION, ... | | Authors: | Alon, G, Zalk, R, Huynh, T.T, Zalutsky, M.R, Weizmann, Y, Zarivach, R, Papo, N. | | Deposit date: | 2024-12-29 | | Release date: | 2025-07-16 | | Last modified: | 2025-07-23 | | Method: | ELECTRON MICROSCOPY (2.46 Å) | | Cite: | Structural analysis of nanobody interactions with their prostate-specific membrane antigen binding epitopes.
Int.J.Biol.Macromol., 320, 2025
|
|
9HVK
 | | PSMA in complex with nanobody 7 and 8 | | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, CALCIUM ION, ... | | Authors: | Alon, G, Zalk, R, Huynh, T.T, Zalutsky, M.R, Weizmann, Y, Zarivach, R, Papo, N. | | Deposit date: | 2024-12-29 | | Release date: | 2025-07-16 | | Last modified: | 2025-07-23 | | Method: | ELECTRON MICROSCOPY (3 Å) | | Cite: | Structural analysis of nanobody interactions with their prostate-specific membrane antigen binding epitopes.
Int.J.Biol.Macromol., 320, 2025
|
|
9HVL
 | | PSMA in complex with nanobody 37 | | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, CALCIUM ION, ... | | Authors: | Alon, G, Zalk, R, Huynh, T.T, Zalutsky, M.R, Weizmann, Y, Zarivach, R, Papo, N. | | Deposit date: | 2024-12-29 | | Release date: | 2025-07-23 | | Method: | ELECTRON MICROSCOPY (2.71 Å) | | Cite: | Structural analysis of nanobody interactions with their prostate-specific membrane antigen binding epitopes.
Int.J.Biol.Macromol., 320, 2025
|
|
5MY6
 | | Crystal structure of a HER2-Nb complex | | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, GLYCEROL, ... | | Authors: | Sterckx, Y.G.-J, D'Huyvetter, M, Devoogdt, N. | | Deposit date: | 2017-01-25 | | Release date: | 2017-08-09 | | Last modified: | 2024-10-23 | | Method: | X-RAY DIFFRACTION (2.246 Å) | | Cite: | (131)I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment.
Clin. Cancer Res., 23, 2017
|
|
9HLW
 | | Prostate Specific Membrane Antigen (PSMA) in complex with nanobody7 | | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, CALCIUM ION, ... | | Authors: | Alon, G, Papo, N, Zarivach, R, Zalk, R. | | Deposit date: | 2024-12-05 | | Release date: | 2025-07-16 | | Last modified: | 2025-07-23 | | Method: | ELECTRON MICROSCOPY (2.66 Å) | | Cite: | Structural analysis of nanobody interactions with their prostate-specific membrane antigen binding epitopes.
Int.J.Biol.Macromol., 320, 2025
|
|
